Cipla

Dr Reddy’s, Cipla & Aurobindo units recall products in US market
India to be hub for Covid-19 anti-viral generic drug: Fitch
Pharma players to launch anti-Covid pill Molnupiravir shortly after DCGI approval
Eli Lilly to transfer rights of two diabetes products to Cipla for better reach
Cipla gets USFDA nod for generic product
Cipla Q1 net profit up 25 pc to Rs 709.92 cr
Read More
logo
DT next
www.dtnext.in